e-learning
resources
Copenhagen 2005
Monday 19.09.2005
Pathogenesis of OSA
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
ACE-inhibitors and obstructive sleep apnoea
C. B. Bucca, L. Brussino, E. Panaro, P. Bigo, L. Mangiardi, A. Cicolin (Turin, Italy)
Source:
Annual Congress 2005 - Pathogenesis of OSA
Session:
Pathogenesis of OSA
Session type:
Thematic Poster Session
Number:
2325
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. B. Bucca, L. Brussino, E. Panaro, P. Bigo, L. Mangiardi, A. Cicolin (Turin, Italy). ACE-inhibitors and obstructive sleep apnoea. Eur Respir J 2005; 26: Suppl. 49, 2325
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Hypertension and obstructive sleep apnoea
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006
Non-CPAP therapies in obstructive sleep apnoea
Source: Guideline 2011
Year: 2011
Ato-oxy as the first successful pharmacotherapy for obstructive sleep apnoea
Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside
Year: 2019
The velumount device for obstructive sleep apnoea
Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea
Year: 2009
Comorbidities of obstructive sleep apnoea syndrome
Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities
Year: 2011
Albuminuria in children with obstructive sleep apnea
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011
Leptin in obstructive sleep apnea
Source: Eur Respir J 2001; 18: Suppl. 33, 333s
Year: 2001
Should caffeine be avoided in obstructive sleep apnea?
Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea
Year: 2009
Metabolic syndrome in obstructive sleep apnoea patients
Source: Annual Congress 2007 - Sleep apnoea
Year: 2007
Can leptin be used to treat obstructive sleep apnoea?
Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside
Year: 2019
Pathophysiological consequences of obstructive sleep apnoea
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006
Change in PLMS after treatment of obstructive sleep apnea
Source: Eur Respir J 2007; 30: Suppl. 51, 593s
Year: 2007
NT-proBNP in obstructive sleep apnoea (OSA)
Source: Eur Respir J 2006; 28: Suppl. 50, 415s
Year: 2006
Predictors of hypercapnia in obstructive sleep apnoea (OSA)
Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control
Year: 2010
Unrecognised systemic hypertension in patients with obstructive sleep apnoea
Source: Eur Respir J 2006; 28: Suppl. 50, 643s
Year: 2006
Awakening headaches are associated with obstructive sleep apnea
Source: Eur Respir J 2002; 20: Suppl. 38, 452s
Year: 2002
Acetazolamide improves central sleep apnea in patients with obstructive sleep apnea syndrome at altitude
Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea
Year: 2009
Vasoconstriction during the night in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 419s
Year: 2006
Unrecognised hypertension in patients screened for obstructive sleep apnoea
Source: Eur Respir J 2005; 26: Suppl. 49, 40s
Year: 2005
Should mixed apnea be classified with obstructive sleep apnea?
Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept